Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia (ATS14)

Clinical Trial ID NCT00789672

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.	Arch Ophthalmol	2010	0.95